drugset
drugset / Trial / NCT01873989

Testosterone Replacement for Male Opioid Agonist Maintained Patients

NCT01873989 ↗

Phase 1/2 Completed 15 enrolled Yale University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction

Timeline

Start
2012-04
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule — —

Indications

chronic pain syndrome hypogonadism, male opiate dependence